NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Tuesday reported a loss of $8.7 million in its second quarter.
The Newark, California-based company said it had a loss of 41 cents per share.
The biopharmaceutical company posted revenue of $11.7 million in the period.
Protagonist Therapeutics shares have fallen 47 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $10.99, a drop of slightly more than 5 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX